Repurposed drugs

‘Klas et al (2023) consider how ethical issues acquired relevance during the COVID-19 pandemic, focusing on amantadine, a drug often used in neurological conditions’

Learning to live with COVID-19

Welcome to this June issue of Journal of Prescribing Practice. It's been a busy time since I last wrote to you all. We have welcomed our new Editor Polly and a lot has been happening in the healthcare...

More than one in six unvaccinated people report health effects of COVID-19 2 years after infection, study finds

‘Understanding the trajectory of symptom burden and recovery from long COVID is crucial for policy making, treatment decisions, and care co-ordination’ .

Mask wearing and COVID-19: What does the evidence say?

The impact of COVID-19 on sexual health services in the UK

The COVID-19 pandemic led to rapid adaptation of health and public health systems on a global scale (Simões et al, 2020). For example, in Beirut, Lebanon, the largest STI and HIV clinics have remained...

Treating those requiring anticoagulation during the COVID-19 pandemic

However, keeping hospital visits to a minimum has required other changes too. In March 2020, NHS England (2020) quickly devised a plan to switch patients who have previously had a blood clot and were...

Setting up a drug treatment service in a COVID-protect hotel in inner London

The hotel was a five-storey building in one of the borough's more affluent areas. Core staff continued to work at the hotel, including domestic and reception staff. Initially catering was outsourced...

A challenging winter lies ahead of us

COVID-19 booster vaccinations

In November 2021 the UK Health Security Agency (2021) announced that those ‘aged 50 years and over, health and social care workers and younger people at risk are being offered a booster dose of...

Healthcare workers must be protected

For many of you in clinical practice, although you have not stopped face-to-face contact, it has not been the same as it has been previously, and many patients have found the pandemic system confusing...

Drug Updates: October

Ronapreve, a combination of two monoclonal antibodies, is the first targeted medicine developed for COVID-19 to receive marketing authorisation from the Medicines and Healthcare products Regulatory...

Overcoming vaccine hesitancy

I'm sure you have all read the more outlandish and outright illogical arguments for not having the COVID-19 vaccine, and these don't really warrant touching upon in a healthcare journal, but there are...